Inhalable nanovaccine with biomimetic coronavirus structure to trigger mucosal immunity of respiratory tract against COVID-19.

Zheng, Bin; Peng, Wenchang; Guo, Mingming; Huang, Mengqian; Gu, Yuxuan; Wang, Tao; Ni, Guangjian; Ming, Dong.

Afiliação

Zheng B; Academy of Medical Engineering and Translational Medicine, Tianjin Key Laboratory of Brain Science and Neural Engineering, Tianjin University, 92 Weijin Road, Nankai District, Tianjin 300072, PR China.
Peng W; Academy of Medical Engineering and Translational Medicine, Tianjin Key Laboratory of Brain Science and Neural Engineering, Tianjin University, 92 Weijin Road, Nankai District, Tianjin 300072, PR China.
Guo M; Academy of Medical Engineering and Translational Medicine, Tianjin Key Laboratory of Brain Science and Neural Engineering, Tianjin University, 92 Weijin Road, Nankai District, Tianjin 300072, PR China.
Huang M; School of Life Sciences, Tianjin University, 92 Weijin Road, Nankai District, Tianjin 300072, PR China.
Gu Y; Academy of Medical Engineering and Translational Medicine, Tianjin Key Laboratory of Brain Science and Neural Engineering, Tianjin University, 92 Weijin Road, Nankai District, Tianjin 300072, PR China.
Wang T; School of Life Sciences, Tianjin University, 92 Weijin Road, Nankai District, Tianjin 300072, PR China.
Ni G; Academy of Medical Engineering and Translational Medicine, Tianjin Key Laboratory of Brain Science and Neural Engineering, Tianjin University, 92 Weijin Road, Nankai District, Tianjin 300072, PR China.
Ming D; Academy of Medical Engineering and Translational Medicine, Tianjin Key Laboratory of Brain Science and Neural Engineering, Tianjin University, 92 Weijin Road, Nankai District, Tianjin 300072, PR China.

Chem Eng J ; 418: 129392, 2021 Aug 15.

Article em En | MEDLINE | ID: mdl-33762883